From: Two staging systems for gastrointestinal stromal tumors in the stomach: which is better?
No. of patients (%) | |
---|---|
Median follow-up duration, month (range) | 44 (6–144) |
Recurrence, n (%) | |
Yes | 9 (6.2) |
No | 136 (93.8) |
Recurrence sitea, n (%) | |
Liver | 5 (45.5) |
Peritoneum | 3 (27.3) |
Spleen | 2 (18.2) |
Operation site | 1 (9.1) |
Recurrence according to NIH consensus criteria | |
Very low | 0/25 (0) |
Low | 0/65 (0) |
Intermediate | 3/23 (13.0) |
High | 6/33 (18.2) |
Recurrence according to 7th UICC/AJCC TNM staging system | |
I | 1/96 (1.0) |
II | 3/34 (8.8) |
IIIA | 4/10 (40) |
IIIB | 1/5 (20) |